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I. Background :
1.Functions & synthesis :  
Beta trace protein (BTP) is a low molecular weight protein synthesized mainly in the central nervous system (CNS). Expressed in tissues of the blood-brain barrier 
and secreted into cerebro-spinal fluid. It catalyses the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent 
inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NREM sleep and PGE-2 allodynia and may have an anti-apoptotic role in 
oligodendrocytes. Binds small non –substrate lipophilic molecules : bilirubin, biliverdin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for 
harmful hydrophobic molecules and as a secretory retinoid and thyroid hormone transporter.
2. BTP as renal marker :
It is freely filtrated in the glomerules and cleared  by the tubules, its amount  in plasma depends mainly from its renal clearance.   Thus different authors have 
proposed to use it as a marker  of renal function. However little is known regarding the analytical performances of its determination, as well as its stability in serum. We 
thus storage and compare its clinical characteristics with different well –established markers of  the Glomerular Filtration Rate (GFR).
II. Material & Methods:
We have assessed the accuracy and precision ( according to  the CLI EP 5A-2 guideline) of BTP determination 
using the Siemens BN 2 (Siemens diagnostics , Tarrytown, NY) nephelometer. We built the accuracy profile on 10 
serum pools (ranging from 0,62 to 20,4 mg/L). We calculated the β expectation limits with β = 0,95 and 
considered  the method as valid if they were comprised in the ± 15% interval. For stability  studies, 10 sample 
assayed in duplicate at T0 and after 1, 4, 7 and  14 days  and after 1, 3, 6 and 12 months. Then we evaluated BTP 
performances  as a marker  of renal function compared to Cystatin C (Cys C; Siemens Diagnostics) in a population  
of patients for whom GFR had been previously determined with a reference method (plasma iohexol clearance). 
III. Results & discussion:
- Repeatability did not exceed 3,1%  and the intermediate precision  5,4%  in the studied range (from 1 to 8,5 mg/L). 
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1.0 1.014 1.487 2.984
2.0 1.036 2.945 4.287
3.0 1.223 3.089 5.365
4.0 2.125 1.862 3.595
5.0 8.523 1.968 4.427
- The accuracy profile built with the 
predictive tolerance interval method shows 
that, on average, 95% of the future results that 
will be generated by this method will be 
included in the computed tolerance  intervals 
of ± 15%  in the studied range. 
-Stability :
BTP was  shown to be stable  after  14 days of 
storage at + 4°C and up to 1 year at -20°C. BTP and  Cys c shows the same classical exponential profile when compared to the GFR in mL/min  determined with the 
reference method. However, we observed a grey- zone  in the range 60-80 mL /min  and we could not determine which 
parameter is the earlier to rise.
N.B :The upper  limit of reference range is shown by the red line : 0,738 mg/L for BTP and  0,95 mg/L for Cystatin C. 
- Correlation between   GFR in mL/min, determined with a reference method (plasma iohexol clearance)  and two 
renal markers  BTP and Cystatin C :
IV. Conclusion : 
BTP  determination on BN2 is  a reliable method that presents interesting analytical characteristics. However, 15% of total variability  should probably be improved, compared to the analytical performances of some other  GFR 
markers (8%  of total variability for Cystatin C and creatinine ). BTP was shown to be very stable molecule at + 4°C and -20°C. Finally , studies with a re ference method in a greater number of patients presenting a GFR in the grey 
zone of 60-80 ml/min  are needed in order to see if BTP could be an earlier marker of renal impairment compared to Cys C and creatinine.
